In the glioma microenvironment, CCL2, released by macrophages and microglia, is crucial for attracting myeloid-derived suppressor cells (MDSCs) and Tregs thus creating an immunosuppressive/tumor supporting environment [61]. This evidence concerns the gene CCL2 and central nervous system cancer.